Circumventing de novo and acquired resistance to trastuzumab: new hope for the care of ErbB2-positive breast cancer. (Q37263115)
Jump to navigation
Jump to search
scientific article published on March 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Circumventing de novo and acquired resistance to trastuzumab: new hope for the care of ErbB2-positive breast cancer. |
scientific article published on March 2008 |
Statements
Circumventing de novo and acquired resistance to trastuzumab: new hope for the care of ErbB2-positive breast cancer (English)